A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India

Author:

Royal AbhishekORCID,John DennyORCID,Bharti OmeshORCID,Tanwar Ritesh,Bhagat Deepak KumarORCID,Padmawati Retna Siwi,Chaudhary Vishal,Umapathi ReddicherlaORCID,Bhadola Pradeep,Utarini Adi

Abstract

Children contribute to one-half of the total painful rabies mortalities in India. The state-of-the-art rabies mortality averting strategies need exploration for the effective implementation of pre-exposure prophylaxis (PrEP) in India. This study reports on the economic evaluation of various PrEP and post-exposure prophylaxis (PEP) strategies to avert rabies mortalities in school-aged children in India. A decision tree model has been developed for children in the age group of 5–15 years to evaluate various PrEP + PEP and PEP only regimens. The 2-site intradermal regimen administered on day zero and seven was chosen as the intervention [PrEP (I)]. ICER was calculated from the quasi-societal and quasi-health systems’ perspectives for the base case analysis, along with one-way sensitivity, and scenario analyses for each regimen. The incremental DALYs averted per million population with the implementation of PrEP (I) ranged between 451 and 85,069 in 2020. The ICER was reported in the range of USD 384–352/DALY averted (non-dominant) in comparison to PEP regimens from a quasi-societal perspective. PrEP (I) is reported to be ‘very cost effective’ in comparison with PEP regimens from the quasi-societal and quasi-health systems’ perspectives and reduce deaths by up to 89.9%. This study concludes that the PrEP (I) regimen is a cost-effective and life-saving strategy to avert painful mortalities due to rabies in school-aged children in India.

Funder

WHO-TDR: Special Program of Implementation Research of Tropical Diseases, Faculty of Medicine, Public Health and Nursing, UGM

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference39 articles.

1. (2018). WHO Expert Consultation on Rabies, Third Report, World Health Organization.

2. A call to accelerate an end to human rabies deaths;Thumbi;Lancet,2022

3. Assessing the burden of human rabies in India: Results of a national multi-center epidemiological survey;Sudarshan;Int. J. Infect. Dis.,2007

4. Burden of illness of dog-mediated rabies in India: A systematic review;John;Clin. Epidemiol. Glob. Health,2021

5. Sudarshan, M.K., Madhusudana, S.N., Mahendra, B.J., Rao, N.S.N., Ashwath Narayana, D.H., Abdul Rahman, S., Meslin, F.-X., Lobo, D., and Ravikumar, G.K. (2022, December 22). Indian Multicentric Rabies Survey 2017; World Health Organization—Association for Prevention and Control of Rabies in India (APRCI), India 2018. Available online: https://fctc.who.int/publications/i/item/world-health-organization---association-for-prevention-and-control-of-rabies-in-india-(aprci)-indian-multicentric-rabies-survey-2017.

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3